David Winchester to Chemotherapy, Adjuvant
This is a "connection" page, showing publications David Winchester has written about Chemotherapy, Adjuvant.
Connection Strength
0.255
-
Multidisciplinary treatment of primary melanoma. Surg Clin North Am. 2009 Feb; 89(1):267-81, xi.
Score: 0.065
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
Score: 0.034
-
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. JAMA Oncol. 2017 Jul 01; 3(7):928-935.
Score: 0.029
-
Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May; 115(6):668-676.
Score: 0.028
-
Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg. 2017 Mar; 213(3):512-515.
Score: 0.028
-
Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. Am J Surg. 2017 Mar; 213(3):521-525.
Score: 0.028
-
External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Surgery. 2016 12; 160(6):1466-1476.
Score: 0.028
-
Survival rates for breast cancers detected in a community service screening mammogram program. Am J Surg. 2006 Mar; 191(3):406-9.
Score: 0.013